Anticorps Polyclonal de lapin anti-KMT2C

KMT2C Polyclonal Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 28437-1-PBS

Synonymes

MLL3, Lysine N methyltransferase 2C, KIAA1506, Homologous to ALR protein, HALR



Informations sur le produit

28437-1-PBS cible KMT2C dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène KMT2C Protéine recombinante Ag28875
Nom complet myeloid/lymphoid or mixed-lineage leukemia 3
Masse moléculaire calculée 541 kDa
Poids moléculaire observé541kDa, 269 kDa
Numéro d’acquisition GenBankNM_170606
Symbole du gène KMT2C
Identification du gène (NCBI) 58508
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Lysine (K)-specific methyltransferase 2C (KMT2C, also known as MLL3) belongs to the mixed-lineage leukemia (MLL) family of histone methyltransferases which methylate the histone 3 tail at lysine 4 (H3K4) as part of the complex proteins associated with Set 1 (COMPASS) complex. Although originally identified as oncogenic fusions in leukemia, genome-wide mutation studies have revealed frequent, presumably loss-of-function, mutations in various members of the MLL family, including MLL2/KMT2B, MLL3/KMT2C, and MLL4/KMT2D in a variety of malignancies, particularly solid tumors. Mechanistic studies of KMT2C in normal cells have focused primarily on its role in enhancer regulation by deposition of H3K4me1 marks.

{{ptg:RelatedPrimaryAntibodies}}